Sigma-Aldrich Posts 4 Percent Q2 Sales Growth, Misses Street Expectation | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 4 percent but fell short of analysts' expectations for the top line.

The St. Louis-based research and chemical products firm reported total revenues of $664 million for the three months ended June 30, up from $637 million for the second quarter of 2011. Analysts, on average, expected sales of $674.7 million.

On an organic basis, Sigma-Aldrich's sales grew 3 percent. Acquisitions added 6 percent to sales growth, while currency exchange reduced its sales by 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?